CSI Market
Sign In | Register

Northwest Biotherapeutics Inc (NWBO) Annual Balance Sheets

Annual · GAAP · USD millions
Access NWBO quarterly Balance Sheets →
The data below summarizes Northwest Biotherapeutics Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3.04
Cash & Short-term Investments3.00
Other Current Assets0.31
Prepaid Expense And Other Assets Current2.17
Total Current Assets5.52
Equipment/Property/Plant Net17.41
Goodwill net0.63
Intangible Assets53.19
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent4.55
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current0.31
Total Assets81.29
Liabilities
Accounts Payable and Accrued Liabilities, Current LI30.82
Derivative Liability, Current DE0.00
Notes Payable, Current NO9.47
Other Liabilities, Current41.79
Deferred Compensation Share-based Arrangements, Liability, Current DE10.21
Business Combination, Contingent Consideration, Liability, Current BU9.42
Total Current Liabilities91.70
Long-term debt12.33
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt12.33
Other liabilities, Noncurrent24.83
Share Liability0.37
Operating Lease Liability Current0.37
Convertible Notes At Fair Value Current32.06
Convertible Notes At Fair Value Non Current5.22
Contingent Payment Obligation Noncurrent1.70
Total Liabilities128.86
Stockholders' Equity
Common Stock Value1.57
Common Stock, Held by Subsidiary etc.-0.08
Additional Paid In Capital Common Stock1,442.83
Retained Earnings / Accumulated Deficit-1,503.66
Accumulated Other Comprehensive Income0.00
Other Equity-13.65
Common Stockholder's Equity-72.99
Non-controlling interests & other12.71
Total Stockholder's Equity-60.28
Liabilities & Stockholder's Equity81.29
4 historic quarters locked

Sign in to unlock the full Northwest Biotherapeutics Inc balance sheet history.

Sign In Create Free Account

About Northwest Biotherapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-043806

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License